pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-628 |
Genomic Coordinates | chr15: 55372940 - 55373034 |
Synonyms | MIRN628, hsa-mir-628, MIR628 |
Description | Homo sapiens miR-628 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-628-3p | ||||||||||||||||||||||||||||
Sequence | 61| UCUAGUAAGAGUGGCAGUCGA |81 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Microarray | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PHLPP2 | ||||||||||||||||||||
Synonyms | PHLPPL, PPM3B | ||||||||||||||||||||
Description | PH domain and leucine rich repeat protein phosphatase 2 | ||||||||||||||||||||
Transcript | NM_015020 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PHLPP2 | |||||||||||||||||||||
3'UTR of PHLPP2 (miRNA target sites are highlighted) |
>PHLPP2|NM_015020|3'UTR 1 CTGCCCCACTGGGCACAGTGTGGGAGGAGGCTGTGCAGGGTTGGGGTAGGGACTTGCTAGAGGCATTCTGCCTCTACATT 81 TCTTTTTGTTTGTTCGTTTTTTTTTTGTTTGTTTGTTTTGAGACGGAGTCTTGCTCAGTCGCTCAGGCTGGAGTGCAATG 161 GTGGGGTCTCGGGTCACTGCAGCCTCTGTCCCTGGGTTCAAGCCATTCTCCTGTCTCAGCCTCCCGAGTAGCTGGGATTA 241 CAGGCACCTGCCATTATGCCCGGCTAAGTTTTATTTTTTTTTTTTAGAGACGGGGTTTCACCATGTTGGCCAGGCTGGTG 321 TTGAACTCTTGACCTCAGGTGATCCACCCTCCTCTGCCTCCCAAAGTGCTGTGATTACAGGCCTCAGCCACCATGCCCAG 401 CCCTGCGTCTACATTTCTAAACCATAGCTGTGTGGGGTTGAACTCGGAGCCAAAAAGTGTGAGAGCCATCAGGGGCTGGC 481 TCTGGATAAACTGGTAGCCACTATCAGTGTTAAGTTTCACATTTAACCTGCATTGGAATTCCCAGGGGTACTGGGAAGAA 561 AGCAGCTGTTCTGTATCAGTCCTACCACCTGCCATTAACCCTTTCTCTCCTAGGATCATTTTGAGAATTTGCCTGCCTGG 641 GCAGGAAAGGGACTATTTCTGTGGAGGAAAAAAGTGAAGATTGATTCTCTTTACTAGTTGCTGCTGATGGATCTCTGTGA 721 CAGAGAAATCACCTTATCTCAGACTAATGGGGTGTGATGTGACTAGTCACATGGCTTTTCATTCTTCTCTACGAGAATAC 801 AGCCTATCAAAATGATGTCTGTTGGAAATGTAGAACCAATCAAACAGATAATTTATGTATGTAATGTAATGAGAGCACTT 881 TTCATTGACTGTGAACTTTTTATTTTTGAATCTGCACTCGAGCCAATCTTCTTAGAGGCAGCCCGGCACCTTCATCCATA 961 GGCAGAGAGAGAACTGGGTGTTGGAGACTTATTCGAGGGTATAGGAAGGGCCCTGTGAAGTTGATTTAACTTTTGGATGT 1041 CAGACTGTGAAAGCTCCTGAGAAACTTGGGGTAATAGGATCTTCTTTTGGGGATGAAAATGGGGAAGGCGTGAGGACCTA 1121 GACTACTTCTCCCTAGATCAGAAAAAGAGAATTACCCCTTGACAAATATGATACCTGCTAGGTATTTCCCAGGGAAATTT 1201 AGGGATTGGCGTCTTTCCCTAGCATGTGGAGGAATTGGCAGACAGCTTCCTAAGGGCGGGGAGCGGGGGCCCAAGGCTGA 1281 CACTGCTTGCATCCACGTGACCTTAAGTTATGGCAGATGACTCTGAAACGGACTGAGGCCAATGAGAACAGATGGATGGA 1361 GCACTCAGGTTAGACTTGTTCCTTCTCCTATGCTGGAGGAGAGGGATGGTTCTCTAGAATGTTGGAGGTGAGTTGAGAGC 1441 TCGCCTCTTGAATGTTGAACAGTGTACTCTTCTGAAAACTGCATATTCACTTTATGTGGTTTCAGAATACTGGGCTCAAT 1521 ACTAACATAAGAAAGACACTTCATTGAGAAATTCTTAAGCTTACAGAAAACCTATACTCTTTGCACATTCCACATAACCC 1601 TAGCAAAATGCAGTTTCTTCATACTTCTGTCACTTTTTCCATTGGAAGATTTGCTTAGGAAAATTAATTCCTATTTATTC 1681 CCACAAAATGTTGGCATTGCTTGATTTTACCCAATGGGGAATGTGCTTTGAATTTTTGGAACACTTTTACAATTAAAAAT 1761 AAAGTAGGGCCATTTTTAATTTGTTTCATCAGAAACTATGTTAAAGAGAGGGTTAAATATAAATATATTTTCGTGTGTAT 1841 TTTTGGGAAGATTTTTGTTCAAAGCAATAGTCAAAATCAGATGACCTGTCCATAATAATTATGTGTCTTCATCTTCTCAG 1921 AGGCCCCATGCTCATATGCACGTGTCATTGGGATACACTCTTGGGGGATTTGGTACACTCTAATGGATGTCTAATGTTCA 2001 ACCCCTCGAGAATCTGAACTTGAGTCCCCAGATTGTCAAACTACTGGTCAGCTATTGAGAATTTTAGAACTCAGGTCTTT 2081 GATTTGAAGTAGGGAACATAGTGGCTCACACAGAGTTTAGGTGCTGTTAGAAAGATGGGAACAAGAGTGTTTTGCCACCT 2161 TATTTTTATATGGGAAATTTTTTTTAATGAAGAAAAAATGAAAATGAAATAACAGGATGATAGTGATGAGTGATGTAAAA 2241 CATCTTACTTAGATGGCAGAACCTTCGGGTTGTAGAATAGTGATGTCTAAAAATTAAAGTTATTTTGGGAATACACCACT 2321 TTAATAGTATAGTCTTATAAAAATTATTCATTATGGTGAACCCTTCTTGTCTGCTATTCGTTTCCCAACCTACTTATTGG 2401 AACCACCTCAAAACCCAGTTCTGAAATGACCTTACCAAAAGTAAATGTATTTATTTTTTAGTCAGCAGAACTCTGTAATT 2481 CCAAATGTTGTTCTGTGTGGTAGAATTTTTTTTCAGGAACCATTAGGTTGTATTGAAAATCTTTGTTATAGGCGATACCA 2561 AAACTGATTATTCTTTTTTGCAGTCTGCTTTAATTCATGTCCTTCTGCAGTTGCTCTGTATTAAAACAGGGTAAAAAGGC 2641 CATAGCCCATTATGAAAAATATAATACAAAACTCTTTGACCTATGAGGTAACTTACAGACATTGTGTTTTCTAAACAGGC 2721 TGTCAGTGAAAGCCCGTATCTGTCTCCAGGTGAATGTAATTTACTTCCGAGTACTTTACCCAGAGGATGTGTTCCCCAGG 2801 TGGGCAGAGTACAGTTGATCTCTAGCACAGACAGAGATTCTGGCCTCTGCATATTCTCAGGTCTCTGTGTGTACCTCCCA 2881 TTGAGTAGAGAAGCTTAAGATAATTTCTGAGAGAAGAACACTGCTGATTGTGGGAGCAGTTTAGGAGTCCATGGAAGAAA 2961 GAAAAATACATGTGTCTTGGCAGCCATGGTGTATTTTTGTCCAAATGGATTGGAAGGATATTTGAATATTTGAATGTTGG 3041 TATGACATAAAGCTGCAGTGCACTATAGAGTCAAGTCATTGAATTACCACTCCTGATACAGGGCTTTATTGTACTACTGT 3121 GAAGTGTATGTGTGCAATACATTGGTGAGTTCATTTACTGGTGTACGGAAGAGCCAGCAGGAGCAGCGTGGTCATTGCTG 3201 GGTGCTATTACAGTTGCTTGTAGTGAGTGCTGTTTTCCAGGAGATGGAGCCAGTTGGGTGTGGCAGATCTACTGAATATC 3281 AAATGATGCTCTTCTTCCCATGTAGACCTTCAGCAAAAGCCGGTACTTGGAAGCCACAGGCTCACCTTCTCTATCTATCC 3361 AATAATTATTAATGAAGAGACCTCCATAAGGGAGCAGCTGGCTGTTATCGATAAATGTACCAATTATTAAATAATTAGTC 3441 TCCAAGCCATTCAGTGATGTCTTCAGCATCACTATAGGACTGTCTAGTGTCACTTTTTACTTCCTTCTGGGTGGAGGCTT 3521 TCCGACTCCCAATCATGAAGGCAAGTTAATCTTTCCAGTTAGTGACTTTTGCCCCATAGTTGGGGTAAGCACTTCCTAGA 3601 TTGAGAAAAAGCAGCTACAGTCAATCCTGCTCTGTTTGCCTCATTTGGTGATCAGTCAGTCACACATAAGTTCCTTGTAT 3681 TCTAAATTTCATGCACTTCTCCCAGATGCTATAGGGTTTTCTCTCACTGTTGCCAGTGGATGTCATCCAGACAGTGGGCT 3761 CATATCTTACGGTTTTGTGCAATCATTGTCGTATTGTAGTCTTAAGACTCATTATAGTGTATTTTTGATATTTTTGAAAT 3841 GTGTTAAATTTTTTAATTCAATAATATGAGCCAGAGCATGTTGCAGCAAATCTATTGTTTGTAAAAATAACAATAACAAT 3921 AATAAATAAAATAAAGTGGAATCTTTTTCATGGCTTTGTTTTAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 23035.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_015020 | 3UTR | GAAGAUUGAUUCUCUUUACUAGUUGCUGCUGAUGGAUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_015020 | 3UTR | UCUGUGGAGGAAAAAAGUGAAGAUUGAUUCUCUUUACUAGUUGCUGCUGAUGGAUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000568954.1 | 3UTR | AUUCUCUUUACUAGUUGCUGCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
27 hsa-miR-628-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT039584 | CDC14A | cell division cycle 14A | 1 | 1 | ||||||||
MIRT039585 | AGO1 | argonaute 1, RISC catalytic component | 2 | 3 | ||||||||
MIRT039586 | TGFBRAP1 | transforming growth factor beta receptor associated protein 1 | 1 | 1 | ||||||||
MIRT039587 | LRP6 | LDL receptor related protein 6 | 1 | 1 | ||||||||
MIRT071876 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT097443 | JMY | junction mediating and regulatory protein, p53 cofactor | 2 | 4 | ||||||||
MIRT100100 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT147692 | CBX4 | chromobox 4 | 2 | 2 | ||||||||
MIRT408248 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT442047 | LRAT | lecithin retinol acyltransferase | 2 | 2 | ||||||||
MIRT444412 | RAB3IP | RAB3A interacting protein | 2 | 2 | ||||||||
MIRT452599 | REPIN1 | replication initiator 1 | 2 | 2 | ||||||||
MIRT469515 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 8 | ||||||||
MIRT498192 | AKR1B10 | aldo-keto reductase family 1 member B10 | 2 | 2 | ||||||||
MIRT500151 | CREBBP | CREB binding protein | 2 | 2 | ||||||||
MIRT507319 | FAM60A | SIN3-HDAC complex associated factor | 2 | 6 | ||||||||
MIRT508343 | ZNF273 | zinc finger protein 273 | 2 | 6 | ||||||||
MIRT520480 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT522461 | MMP16 | matrix metallopeptidase 16 | 2 | 4 | ||||||||
MIRT547116 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | 2 | 2 | ||||||||
MIRT548675 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 2 | 2 | ||||||||
MIRT553756 | TARBP2 | TARBP2, RISC loading complex RNA binding subunit | 2 | 4 | ||||||||
MIRT559437 | ARSJ | arylsulfatase family member J | 2 | 2 | ||||||||
MIRT610490 | GPC4 | glypican 4 | 2 | 2 | ||||||||
MIRT644682 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT658214 | FBXO21 | F-box protein 21 | 2 | 2 | ||||||||
MIRT756083 | TP53 | tumor protein p53 | 4 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|